Eli Lilly and Company CEO to Undergo Surgery, CFO Rice to Become Interim CEO

Published: May 07, 2013

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Eli Lilly & Co's longtime Chief Executive John Lechleiter will undergo surgery next Monday for a dilated aorta, but is expected to make a full recovery from the potentially dangerous condition and return to work this summer, the drugmaker said on Monday. Lilly Chief Financial Officer Derica Rice, 48, will assume the additional role of acting CEO during Lechleiter's surgery and recovery period, the Indianapolis drugmaker said. Lechleiter, 59, had no symptoms of the condition, but learned of it during recent unrelated medical testing, Lilly said. Rice and Lechleiter have worked closely together over the past four years in formulating plans to revive Lilly's earnings and sales after ongoing generic competition for some of its biggest drugs, including its Zyprexa schizophrenia drug.

Help employers find you! Check out all the jobs and post your resume.

Back to news